KA
Keene & Associates’s Lifecore Biomedical LFCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,410
| Closed | -$110K | – | 79 |
|
|
2024
Q3 | $110K | Hold |
22,410
| – | – | 0.08% | 75 |
|
|
2024
Q2 | $115K | Hold |
22,410
| – | – | 0.09% | 72 |
|
|
2024
Q1 | $119K | Buy |
22,410
+475
| +2% | +$2.52K | 0.09% | 79 |
|
|
2023
Q4 | $136K | Sell |
21,935
-2,000
| -8% | -$12.4K | 0.11% | 77 |
|
|
2023
Q3 | $181K | Sell |
23,935
-165
| -0.7% | -$1.25K | 0.14% | 78 |
|
|
2023
Q2 | $233K | Hold |
24,100
| – | – | 0.18% | 74 |
|
|
2023
Q1 | $91K | Buy |
24,100
+10,700
| +80% | +$40.4K | 0.07% | 76 |
|
|
2022
Q4 | $86.8K | Sell |
13,400
-12,800
| -49% | -$82.9K | 0.08% | 73 |
|
|
2022
Q3 | $233K | Hold |
26,200
| – | – | 0.21% | 71 |
|
|
2022
Q2 | $261K | Buy |
26,200
+3,455
| +15% | +$34.4K | 0.24% | 66 |
|
|
2022
Q1 | $263K | Buy |
22,745
+4,790
| +27% | +$55.4K | 0.21% | 71 |
|
|
2021
Q4 | $199K | Buy |
+17,955
| New | +$199K | 0.17% | 76 |
|